Bora and Insilico Form 2.5 Billion Dollar Partnership

Taiwanese drugmaker Bora Pharmaceuticals and Insilico Medicine are partnering to enhance manufacturing efficiency and drug development through automation. The collaboration is valued at over 2.5 billion dollars and aims to create a scalable model for advancing proprietary pharmaceutical assets.